Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Kening Li, Bin Huang, Min Wu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 240

Showing 1-25 of 240 citing articles:

Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor, Andrew C. Adams, Matthew M. Hufford, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 382-393
Open Access | Times Cited: 706
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 397, Iss. 10289, pp. 2049-2059
Open Access | Times Cited: 471
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 440
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Jun Wu, Boyun Liang, Cunrong Chen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 224
Sex-based clinical and immunological differences in COVID-19
Bin Huang, Yun Cai, Ning Li, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 192
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 176
Ultrafast, sensitive, and portable detection of COVID-19 IgG using flexible organic electrochemical transistors
Hong Liu, Anneng Yang, Jiajun Song, et al.
Science Advances (2021) Vol. 7, Iss. 38
Open Access | Times Cited: 161
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.
EClinicalMedicine (2021) Vol. 32, pp. 100734-100734
Open Access | Times Cited: 152
Immune response in COVID-19: what is next?
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 110
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity
Irina Arkhipova-Jenkins, Mark Helfand, Charlotte Armstrong, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 6, pp. 811-821
Open Access | Times Cited: 108
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
C. Avendaño, António Ramos, Elena Múñez, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 104
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
Miriam Echaide, Luisa Chocarro, Ana Bocanegra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5944-5944
Open Access | Times Cited: 51
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 72
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 67
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors
Evangelos Terpos, Dimitris Stellas, Margherita Rosati, et al.
European Journal of Internal Medicine (2021) Vol. 89, pp. 87-96
Open Access | Times Cited: 63
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Lise J Estcourt, Leon Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 61
Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection
Julien Favresse, Christine Eucher, Marc Elsen, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 556-556
Open Access | Times Cited: 59
Rapid and highly sensitive one-tube colorimetric RT-LAMP assay for visual detection of SARS-CoV-2 RNA
Yugan He, Tie Xie, Yigang Tong
Biosensors and Bioelectronics (2021) Vol. 187, pp. 113330-113330
Open Access | Times Cited: 58
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
Maurice Steenhuis, Gerard van Mierlo, Ninotska I. L. Derksen, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 5
Open Access | Times Cited: 57
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals
Alessandra Ruggiero, Chiara Piubelli, Lucia Calciano, et al.
EBioMedicine (2022) Vol. 77, pp. 103888-103888
Open Access | Times Cited: 54
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection
Costanza Di Chiara, Anna Cantarutti, Paola Costenaro, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2221616-e2221616
Open Access | Times Cited: 52
SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
Emi E. Nakayama, Tatsuo Shioda
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1015-1015
Open Access | Times Cited: 21
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine
Ana M. Espino, Albersy Armina-Rodríguez, Laura Alvarez, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 187-187
Open Access | Times Cited: 9
Advances in Neutralization Assays for SARS‐CoV‐2
Yuying Lu, Wang Jin, Qianlin Li, et al.
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 3
Open Access | Times Cited: 51
Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing
Zehui Zhang, Xiaoqin Wang, Xiaojun Wei, et al.
Biosensors and Bioelectronics (2021) Vol. 181, pp. 113134-113134
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top